Posted by Michael Wonder on 31 Oct 2024
Sugemalimab approved to treat adult patients with non-small cell lung cancer
30 October 2024 - The MHRA has today approved sugemalimab (Eqjubi) to treat adult patients with non-small cell lung cancer.
Clinical trials showed that sugemalimab in combination with platinum-based chemotherapy was more effective than placebo in patients with stage 4 metastatic lung cancer.
